Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5271361
Max Phase: Preclinical
Molecular Formula: C19H23ClO5
Molecular Weight: 366.84
Associated Items:
ID: ALA5271361
Max Phase: Preclinical
Molecular Formula: C19H23ClO5
Molecular Weight: 366.84
Associated Items:
Canonical SMILES: C/C1=C\CCC(C)(C)C(C)OC(=O)Cc2c(Cl)c(O)cc(O)c2C1=O
Standard InChI: InChI=1S/C19H23ClO5/c1-10-6-5-7-19(3,4)11(2)25-15(23)8-12-16(18(10)24)13(21)9-14(22)17(12)20/h6,9,11,21-22H,5,7-8H2,1-4H3/b10-6+
Standard InChI Key: SJMLJWOLGMOTLG-UXBLZVDNSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 366.84 | Molecular Weight (Monoisotopic): 366.1234 | AlogP: 4.17 | #Rotatable Bonds: 0 |
Polar Surface Area: 83.83 | Molecular Species: ACID | HBA: 5 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 6.39 | CX Basic pKa: | CX LogP: 5.08 | CX LogD: 4.05 |
Aromatic Rings: 1 | Heavy Atoms: 25 | QED Weighted: 0.67 | Np Likeness Score: 2.07 |
1. Seipp K, Groß J, Kiefer AM, Erkel G, Opatz T.. (2023) Total Synthesis and Biological Evaluation of the Anti-Inflammatory (13R,14S,15R)-13-Hydroxy-14-deoxyoxacyclododecindione., 86 (4): [PMID:37001011] [10.1021/acs.jnatprod.2c01145] |
Source(1):